We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAS:NYSEMasco Corporation Analysis

Data as of 2026-03-13 - not real-time

$61.55

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Masco Corp. (MAS) is trading at $61.55, just above the calculated support of $60.51 and well below the 20‑day SMA of $69.53, indicating a price that is testing a near‑term floor. Technical signals are mixed: the RSI of 29.96 suggests the stock is oversold, while the MACD histogram remains negative, signaling bearish momentum. Despite a modest Q4 earnings beat (adjusted EPS $0.797 vs. $0.78 expectations), revenue fell 2% in local currency, extending a 1.9% year‑over‑year decline. The company’s dividend yield of 2.11% with a 32% payout ratio is supported by solid operating cash flow of $1.02 B, but the balance sheet is strained, featuring a debt‑to‑equity ratio of over 4,200 and a negative book value per share of –$0.91. Valuation metrics are divergent: the DCF‑derived fair value of $32 is far below the current price, yet the stock’s P/E of 15.95 is well under the industry average of 29.13, hinting at a potential value angle.
Overall, MAS presents a high‑yield, cash‑generating profile marred by high leverage and a valuation gap, while market sentiment leans bullish (fear‑greed index at 73) and volatility remains elevated at 40.5% over 30 days. Investors should weigh the oversold technical backdrop and dividend appeal against the substantial debt load and overvaluation relative to intrinsic estimates.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above key support level
  • Oversold RSI indicating potential rebound
  • Bearish MACD histogram suggesting continued downside pressure

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Stable dividend yield with sustainable payout ratio
  • Bullish trend direction despite price below short‑term averages
  • High leverage and negative book value limiting upside potential

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Significant debt‑to‑equity ratio and negative equity base
  • Current price far exceeds DCF fair value
  • Revenue contraction and modest growth outlook

Key Metrics & Analysis

Financial Health

Revenue Growth-1.90%
Profit Margin10.71%
P/E Ratio15.9
ROE7150.00%
ROA15.49%
Debt/Equity4230.26
P/B Ratio-67.9
Op. Cash Flow$1.0B
Free Cash Flow$663.1M
Industry P/E29.1

Technical Analysis

TrendBullish
RSI30.0
Support$60.51
Resistance$77.85
MA 20$69.53
MA 50$69.31
MA 200$67.54
MACDBearish
VolumeStable
Fear & Greed Index73.02

Valuation

Fair Value$32.01
Target Price$80.32
Upside/Downside30.49%
GradeOvervalued
TypeBlend
Dividend Yield2.11%

Risk Assessment

Beta0.98
Volatility40.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.